ProCE Banner Activity

SOLAR 3D: Wk 48 Results of Switching to DTG/3TC From Suppressive 3- or 4-Drug ART in PWH With M184V/I Mutations and Virologic Failure

Slideset Download
Conference Coverage
In open-label study, 2-drug regimen was found to be safe and effective at maintaining virologic suppression in patients with multiple previous virologic failures and historic or current M184V/I.

Released: November 02, 2021

Expiration: November 01, 2022

Share

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Gilead Sciences, Inc.

Merck Sharp & Dohme Corp.

ViiV Healthcare